<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32781521</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>02</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>02</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>16</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Aug</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Ephs and Ephrins in Adult Endothelial Biology.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">5623</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21165623</ELocationID>
        <Abstract>
          <AbstractText>Eph receptors and their ephrin ligands are important guidance molecules during neurological and vascular development. In recent years, it has become clear that the Eph protein family remains functional in adult physiology. A subset of Ephs and ephrins is highly expressed by endothelial cells. As endothelial cells form the first barrier between the blood and surrounding tissues, maintenance of a healthy endothelium is crucial for tissue homeostasis. This review gives an overview of the current insights of the role of ephrin ligands and receptors in endothelial function and leukocyte recruitment in the (patho)physiology of adult vascular biology.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Vreeken</LastName>
            <ForeName>Dianne</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0002-8228-8233</Identifier>
            <AffiliationInfo>
              <Affiliation>Einthoven Laboratory for Vascular and Regenerative Medicine, Department of Internal Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Huayu</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Einthoven Laboratory for Vascular and Regenerative Medicine, Department of Internal Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Zonneveld</LastName>
            <ForeName>Anton Jan</ForeName>
            <Initials>AJ</Initials>
            <Identifier Source="ORCID">0000-0002-1676-7738</Identifier>
            <AffiliationInfo>
              <Affiliation>Einthoven Laboratory for Vascular and Regenerative Medicine, Department of Internal Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>van Gils</LastName>
            <ForeName>Janine M</ForeName>
            <Initials>JM</Initials>
            <Identifier Source="ORCID">0000-0003-2429-7462</Identifier>
            <AffiliationInfo>
              <Affiliation>Einthoven Laboratory for Vascular and Regenerative Medicine, Department of Internal Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>08</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D036342">Ephrins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.10.1</RegistryNumber>
          <NameOfSubstance UI="D036081">Receptors, Eph Family</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName>
          <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036342" MajorTopicYN="N">Ephrins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006706" MajorTopicYN="N">Homeostasis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036081" MajorTopicYN="N">Receptors, Eph Family</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Eph–Ephrin signaling</Keyword>
        <Keyword MajorTopicYN="N">blood vessels</Keyword>
        <Keyword MajorTopicYN="N">endothelial cells</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32781521</ArticleId>
        <ArticleId IdType="pmc">PMC7460586</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms21165623</ArticleId>
        <ArticleId IdType="pii">ijms21165623</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hirai H., Maru Y., Hagiwara K., Nishida J., Takaku F. A novel putative tyrosine kinase receptor encoded by the eph gene. Science. 1987;238:1717–1720. doi: 10.1126/science.2825356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.2825356</ArticleId>
            <ArticleId IdType="pubmed">2825356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kania A., Klein R. Mechanisms of Ephrin-Eph Signalling in Development, Physiology and Disease. Nat. Rev. Mol. Cell Biol. 2016;17:240–256. doi: 10.1038/nrm.2015.16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm.2015.16</ArticleId>
            <ArticleId IdType="pubmed">26790531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang H.U., Chen Z.-F., Anderson D.J. Molecular Distinction and Angiogenic Interaction between Embryonic Arteries and Veins Revealed by ephrin-B2 and Its Receptor Eph-B4. Cell. 1998;93:741–753. doi: 10.1016/S0092-8674(00)81436-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(00)81436-1</ArticleId>
            <ArticleId IdType="pubmed">9630219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerety S.S., Wang H.U., Chen Z.F., Anderson D.J. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell. 1999;4:403–414. doi: 10.1016/S1097-2765(00)80342-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1097-2765(00)80342-1</ArticleId>
            <ArticleId IdType="pubmed">10518221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darling T.K., Lamb T.J. Emerging Roles for Eph Receptors and Ephrin Ligands in Immunity. Front. Immunol. 2019;10 doi: 10.3389/fimmu.2019.01473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2019.01473</ArticleId>
            <ArticleId IdType="pmc">PMC6620610</ArticleId>
            <ArticleId IdType="pubmed">31333644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michiels C. Endothelial cell functions. J. Cell. Physiol. 2003;196:430–443. doi: 10.1002/jcp.10333.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.10333</ArticleId>
            <ArticleId IdType="pubmed">12891700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kullander K., Klein R. Mechanisms and functions of Eph and ephrin signalling. Nat. Rev. Mol. Cell Biol. 2002;3:475–486. doi: 10.1038/nrm856.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm856</ArticleId>
            <ArticleId IdType="pubmed">12094214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lisabeth E.M., Falivelli G., Pasquale E.B. Eph receptor signaling and ephrins. Cold Spring Harb. Perspect. Biol. 2013;5 doi: 10.1101/cshperspect.a009159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/cshperspect.a009159</ArticleId>
            <ArticleId IdType="pmc">PMC3753714</ArticleId>
            <ArticleId IdType="pubmed">24003208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salvucci O., Tosato G. Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Adv. Cancer Res. 2012;114:21–57. doi: 10.1016/b978-0-12-386503-8.00002-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/b978-0-12-386503-8.00002-8</ArticleId>
            <ArticleId IdType="pmc">PMC3500853</ArticleId>
            <ArticleId IdType="pubmed">22588055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu N.J., Henkemeyer M. Ephrin reverse signaling in axon guidance and synaptogenesis. SEMIN Cell Dev. Biol. 2012;23:58–64. doi: 10.1016/j.semcdb.2011.10.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2011.10.024</ArticleId>
            <ArticleId IdType="pmc">PMC3288821</ArticleId>
            <ArticleId IdType="pubmed">22044884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasquale E.B. Eph-Ephrin Bidirectional Signaling in Physiology and Disease. Cell. 2008;133:38–52. doi: 10.1016/j.cell.2008.03.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2008.03.011</ArticleId>
            <ArticleId IdType="pubmed">18394988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Funk S.D., Yurdagul A., Jr., Albert P., Traylor J.G., Jr., Jin L., Chen J., Orr A.W. EphA2 activation promotes the endothelial cell inflammatory response: A potential role in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012;32:686–695. doi: 10.1161/ATVBAHA.111.242792.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.111.242792</ArticleId>
            <ArticleId IdType="pmc">PMC3325141</ArticleId>
            <ArticleId IdType="pubmed">22247258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiedemann E., Jellinghaus S., Ende G., Augstein A., Sczech R., Wielockx B., Weinert S., Strasser R.H., Poitz D.M. Regulation of endothelial migration and proliferation by ephrin-A1. Cell. Signal. 2017;29:84–95. doi: 10.1016/j.cellsig.2016.10.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2016.10.003</ArticleId>
            <ArticleId IdType="pubmed">27742560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen F., Liu Z., Peng W., Gao Z., Ouyang H., Yan T., Ding S., Cai Z., Zhao B., Mao L., et al.  Activation of EphA4 induced by EphrinA1 exacerbates disruption of the blood-brain barrier following cerebral ischemia-reperfusion via the Rho/ROCK signaling pathway. Exp. Med. 2018;16:2651–2658. doi: 10.3892/etm.2018.6460.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/etm.2018.6460</ArticleId>
            <ArticleId IdType="pmc">PMC6122430</ArticleId>
            <ArticleId IdType="pubmed">30186497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohura N., Yamamoto K., Ichioka S., Sokabe T., Nakatsuka H., Baba A., Shibata M., Nakatsuka T., Harii K., Wada Y., et al.  Global analysis of shear stress-responsive genes in vascular endothelial cells. J. Atheroscler. Thromb. 2003;10:304–313. doi: 10.5551/jat.10.304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5551/jat.10.304</ArticleId>
            <ArticleId IdType="pubmed">14718748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fasanaro P., D’Alessandra Y., Di Stefano V., Melchionna R., Romani S., Pompilio G., Capogrossi M.C., Martelli F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 2008;283:15878–15883. doi: 10.1074/jbc.M800731200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M800731200</ArticleId>
            <ArticleId IdType="pmc">PMC3259646</ArticleId>
            <ArticleId IdType="pubmed">18417479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao F., Qiu H., Zhou L., Shen X., Yang L., Ding K. WSS25 inhibits Dicer, downregulating microRNA-210, which targets Ephrin-A3, to suppress human microvascular endothelial cell (HMEC-1) tube formation. Glycobiology. 2013;23:524–535. doi: 10.1093/glycob/cwt004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/glycob/cwt004</ArticleId>
            <ArticleId IdType="pubmed">23322395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu H., Wang J., Chen Y., Chen Y., Ma X., Bihl J.C., Yang Y. NPC-EXs Alleviate Endothelial Oxidative Stress and Dysfunction through the miR-210 Downstream Nox2 and VEGFR2 Pathways. Oxidative Med. Cell. Longev. 2017;2017:9397631. doi: 10.1155/2017/9397631.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2017/9397631</ArticleId>
            <ArticleId IdType="pmc">PMC5467331</ArticleId>
            <ArticleId IdType="pubmed">28630660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu H., Devraj K., Moller K., Liebner S., Hecker M., Korff T. EphrinB-mediated reverse signalling controls junctional integrity and pro-inflammatory differentiation of endothelial cells. Thromb. Haemost. 2014;112:151–163. doi: 10.1160/TH13-12-1034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1160/TH13-12-1034</ArticleId>
            <ArticleId IdType="pubmed">24522257</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korff T., Dandekar G., Pfaff D., Fuller T., Goettsch W., Morawietz H., Schaffner F., Augustin H.G. Endothelial ephrinB2 is controlled by microenvironmental determinants and associates context-dependently with CD31. Arterioscler. Thromb. Vasc. Biol. 2006;26:468–474. doi: 10.1161/01.ATV.0000200081.42064.e7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.ATV.0000200081.42064.e7</ArticleId>
            <ArticleId IdType="pubmed">16357318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Gils J.M., Ramkhelawon B., Fernandes L., Stewart M.C., Guo L., Seibert T., Menezes G.B., Cara D.C., Chow C., Kinane T.B., et al.  Endothelial expression of guidance cues in vessel wall homeostasis dysregulation under proatherosclerotic conditions. Arterioscler. Thromb. Vasc. Biol. 2013;33:911–919. doi: 10.1161/ATVBAHA.112.301155.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.112.301155</ArticleId>
            <ArticleId IdType="pmc">PMC3647028</ArticleId>
            <ArticleId IdType="pubmed">23430612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Korff T., Braun J., Pfaff D., Augustin H.G., Hecker M. Role of ephrinB2 expression in endothelial cells during arteriogenesis: Impact on smooth muscle cell migration and monocyte recruitment. Blood. 2008;112:73–81. doi: 10.1182/blood-2007-12-128835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2007-12-128835</ArticleId>
            <ArticleId IdType="pubmed">18445690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masumura T., Yamamoto K., Shimizu N., Obi S., Ando J. Shear stress increases expression of the arterial endothelial marker ephrinB2 in murine ES cells via the VEGF-Notch signaling pathways. Arterioscler. Thromb. Vasc. Biol. 2009;29:2125–2131. doi: 10.1161/ATVBAHA.109.193185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.109.193185</ArticleId>
            <ArticleId IdType="pubmed">19797707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Model L.S., Hall M.R., Wong D.J., Muto A., Kondo Y., Ziegler K.R., Feigel A., Quint C., Niklason L., Dardik A. Arterial shear stress reduces eph-b4 expression in adult human veins. Yale J. Biol. Med. 2014;87:359–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4144290</ArticleId>
            <ArticleId IdType="pubmed">25191151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki Y., Yamamoto K., Ando J., Matsumoto K., Matsuda T. Arterial shear stress augments the differentiation of endothelial progenitor cells adhered to VEGF-bound surfaces. Biochem. Biophys. Res. Commun. 2012;423:91–97. doi: 10.1016/j.bbrc.2012.05.088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2012.05.088</ArticleId>
            <ArticleId IdType="pubmed">22634005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goettsch W., Augustin H.G., Morawietz H. Down-regulation of endothelial ephrinB2 expression by laminar shear stress. Endothel. J. Endothel. Cell Res. 2004;11:259–265. doi: 10.1080/10623320490904151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/10623320490904151</ArticleId>
            <ArticleId IdType="pubmed">15763946</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang W., Feng L., Zhang H., Hachy S., Satohisa S., Laurent L.C., Parast M., Zheng J., Chen D.B. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. J. Clin. Endocrinol. Metab. 2012;97:E1051–E1059. doi: 10.1210/jc.2011-3131.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2011-3131</ArticleId>
            <ArticleId IdType="pmc">PMC3387422</ArticleId>
            <ArticleId IdType="pubmed">22438230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Good R.J., Hernandez-Lagunas L., Allawzi A., Maltzahn J.K., Vohwinkel C.U., Upadhyay A.K., Kompella U., Birukov K.G., Carpenter T.C., Sucharov C.C., et al.  MicroRNA Dysregulation in Lung Injury: The Role of the miR-26a/EphA2 Axis in Regulation of Endothelial Permeability. Am. J. Physiol. Lung Cell. Mol. Physiol. 2018;315 doi: 10.1152/ajplung.00073.2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajplung.00073.2017</ArticleId>
            <ArticleId IdType="pmc">PMC6230876</ArticleId>
            <ArticleId IdType="pubmed">30024304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu Y., Heng X., Yu J., Su Q., Guan X., You C., Wang L., Che F. miR-137 regulates the migration of human umbilical vein endothelial cells by targeting ephrin-type A receptor 7. Mol. Med. Rep. 2014;10:1475–1480. doi: 10.3892/mmr.2014.2319.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3892/mmr.2014.2319</ArticleId>
            <ArticleId IdType="pubmed">24927112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keung M.H., Chan L.S., Kwok H.H., Wong R.N., Yue P.Y. Role of microRNA-520h in 20(R)-ginsenoside-Rg3-mediated angiosuppression. J. Ginseng Res. 2016;40:151–159. doi: 10.1016/j.jgr.2015.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jgr.2015.07.002</ArticleId>
            <ArticleId IdType="pmc">PMC4845046</ArticleId>
            <ArticleId IdType="pubmed">27158236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zamora D.O., Babra B., Pan Y., Planck S.R., Rosenbaum J.T. Human leukocytes express ephrinB2 which activates microvascular endothelial cells. Cell. Immunol. 2006;242:99–109. doi: 10.1016/j.cellimm.2006.10.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellimm.2006.10.001</ArticleId>
            <ArticleId IdType="pubmed">17123494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gale N.W., Baluk P., Pan L., Kwan M., Holash J., DeChiara T.M., McDonald D.M., Yancopoulos G.D. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev. Biol. 2001;230:151–160. doi: 10.1006/dbio.2000.0112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/dbio.2000.0112</ArticleId>
            <ArticleId IdType="pubmed">11161569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shin D., Garcia-Cardena G., Hayashi S.-I., Gerety S., Asahara T., Stavrakis G., Isner J., Folkman J., Gimbrone M.A., Jr., Anderson D.J. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev. Biol. 2001;230:139–150. doi: 10.1006/dbio.2000.9957.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/dbio.2000.9957</ArticleId>
            <ArticleId IdType="pubmed">11161568</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salvucci O., de la Luz Sierra M., Martina J.A., McCormick P.J., Tosato G. EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling. Blood. 2006;108:2914–2922. doi: 10.1182/blood-2006-05-023341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2006-05-023341</ArticleId>
            <ArticleId IdType="pmc">PMC1895526</ArticleId>
            <ArticleId IdType="pubmed">16840724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakamoto A., Sugamoto Y., Tokunaga Y., Yoshimuta T., Hayashi K., Konno T., Kawashiri M.A., Takeda Y., Yamagishi M. Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells. J. Int. Med. Res. 2011;39:522–527. doi: 10.1177/147323001103900220.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/147323001103900220</ArticleId>
            <ArticleId IdType="pubmed">21672356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Y., Zagoura D., Keck C., Pietrowski D. Expression of Eph receptor tyrosine kinases and their ligands in human Granulosa lutein cells and human umbilical vein endothelial cells. Exp. Clin. Endocrinol. Diabetes Off. J. Ger. Soc. Endocrinol. Ger. Diabetes Assoc. 2006;114:590–595. doi: 10.1055/s-2006-950499.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2006-950499</ArticleId>
            <ArticleId IdType="pubmed">17177142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larson J., Schomberg S., Schroeder W., Carpenter T.C. Endothelial EphA receptor stimulation increases lung vascular permeability. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008;295:L431–L439. doi: 10.1152/ajplung.90256.2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajplung.90256.2008</ArticleId>
            <ArticleId IdType="pmc">PMC2536794</ArticleId>
            <ArticleId IdType="pubmed">18599503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miao Z., Dong Y., Fang W., Shang D., Liu D., Zhang K., Li B., Chen Y.H. VEGF increases paracellular permeability in brain endothelial cells via upregulation of EphA2. Anat. Rec. 2014;297:964–972. doi: 10.1002/ar.22878.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ar.22878</ArticleId>
            <ArticleId IdType="pubmed">24458982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carpenter T.C., Schroeder W., Stenmark K.R., Schmidt E.P. Eph-A2 Promotes Permeability and Inflammatory Responses to Bleomycin-Induced Lung Injury. Am. J. Respir. Cell Mol. Biol. 2012;46:40–47. doi: 10.1165/rcmb.2011-0044OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1165/rcmb.2011-0044OC</ArticleId>
            <ArticleId IdType="pmc">PMC3262654</ArticleId>
            <ArticleId IdType="pubmed">21799118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Brien J., Hayder H., Zayed Y., Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front. Endocrinol. 2018;9 doi: 10.3389/fendo.2018.00402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fendo.2018.00402</ArticleId>
            <ArticleId IdType="pmc">PMC6085463</ArticleId>
            <ArticleId IdType="pubmed">30123182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernández-Hernando C., Suárez Y. MicroRNAs in endothelial cell homeostasis and vascular disease. Curr. Opin. Hematol. 2018;25:227–236. doi: 10.1097/MOH.0000000000000424.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MOH.0000000000000424</ArticleId>
            <ArticleId IdType="pmc">PMC6175704</ArticleId>
            <ArticleId IdType="pubmed">29547400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shu Z., Tan J., Miao Y., Zhang Q. The role of microvesicles containing microRNAs in vascular endothelial dysfunction. J. Cell. Mol. Med. 2019;23:7933–7945. doi: 10.1111/jcmm.14716.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jcmm.14716</ArticleId>
            <ArticleId IdType="pmc">PMC6850938</ArticleId>
            <ArticleId IdType="pubmed">31576661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santulli G. MicroRNAs and Endothelial (Dys) Function. J. Cell. Physiol. 2016;231:1638–1644. doi: 10.1002/jcp.25276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.25276</ArticleId>
            <ArticleId IdType="pmc">PMC4871250</ArticleId>
            <ArticleId IdType="pubmed">26627535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Zonneveld A.-J., Rabelink T.J. Endothelial progenitor cells: Biology and therapeutic potential in hypertension. Curr. Opin. Nephrol. Hypertens. 2006;15:167–172. doi: 10.1097/01.mnh.0000214774.42103.ec.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.mnh.0000214774.42103.ec</ArticleId>
            <ArticleId IdType="pubmed">16481884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brantley-Sieders D.M., Caughron J., Hicks D., Pozzi A., Ruiz J.C., Chen J. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation. J. Cell Sci. 2004;117:2037–2049. doi: 10.1242/jcs.01061.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.01061</ArticleId>
            <ArticleId IdType="pubmed">15054110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinle J.J., Meininger C.J., Forough R., Wu G., Wu M.H., Granger H.J. Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 2002;277:43830–43835. doi: 10.1074/jbc.M207221200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M207221200</ArticleId>
            <ArticleId IdType="pubmed">12235151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng L.C., Wang X.Q., Lu K., Deng X.L., Zhang C.W., Luo H., Xu X.D., Chen X.M., Yan L., Wang Y.Q., et al.  Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells. Oncotarget. 2017;8:41348–41363. doi: 10.18632/oncotarget.17298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.17298</ArticleId>
            <ArticleId IdType="pmc">PMC5522204</ArticleId>
            <ArticleId IdType="pubmed">28489586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sturz A., Bader B., Thierauch K.H., Glienke J. EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration. Biochem. Biophys. Res. Commun. 2004;313:80–88. doi: 10.1016/j.bbrc.2003.11.092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2003.11.092</ArticleId>
            <ArticleId IdType="pubmed">14672701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamada K., Oike Y., Ito Y., Maekawa H., Miyata K., Shimomura T., Suda T. Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2003;23:190–197. doi: 10.1161/01.ATV.0000055440.89758.C2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.ATV.0000055440.89758.C2</ArticleId>
            <ArticleId IdType="pubmed">12588758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jadlowiec C.C., Feigel A., Yang C., Feinstein A.J., Kim S.T., Collins M.J., Kondo Y., Muto A., Dardik A. Reduced adult endothelial cell EphB4 function promotes venous remodeling. Am. J. Physiol. Cell Physiol. 2013;304:C627–C635. doi: 10.1152/ajpcell.00333.2012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpcell.00333.2012</ArticleId>
            <ArticleId IdType="pmc">PMC3625716</ArticleId>
            <ArticleId IdType="pubmed">23269240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zuo K., Zhi K., Zhang X., Lu C., Wang S., Li M., He B. A dysregulated microRNA-26a/EphA2 axis impairs endothelial progenitor cell function via the p38 MAPK/VEGF pathway. Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 2015;35:477–488. doi: 10.1159/000369713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000369713</ArticleId>
            <ArticleId IdType="pubmed">25613580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foubert P., Silvestre J.S., Souttou B., Barateau V., Martin C., Ebrahimian T.G., Lere-Dean C., Contreres J.O., Sulpice E., Levy B.I., et al.  PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells. J. Clin. Investig. 2007;117:1527–1537. doi: 10.1172/JCI28338.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI28338</ArticleId>
            <ArticleId IdType="pmc">PMC1866248</ArticleId>
            <ArticleId IdType="pubmed">17510705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foubert P., Squiban C., Holler V., Buard V., Dean C., Levy B.I., Benderitter M., Silvestre J.S., Tobelem G., Tamarat R. Strategies to Enhance the Efficiency of Endothelial Progenitor Cell Therapy by Ephrin B2 Pretreatment and Coadministration with Smooth Muscle Progenitor Cells on Vascular Function During the Wound-Healing Process in Irradiated or Nonirradiated Condition. Cell Transplant. 2015;24:1343–1361. doi: 10.3727/096368913X672064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3727/096368913X672064</ArticleId>
            <ArticleId IdType="pubmed">24069908</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X., Luo Q., Zheng Y., Liu X., Hu Y., Liu W., Luo M., Zhao Y., Zou L. NOTCH4 signaling controls EFNB2-induced endothelial progenitor cell dysfunction in preeclampsia. Reproduction. 2016;152:47–55. doi: 10.1530/REP-16-0132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1530/REP-16-0132</ArticleId>
            <ArticleId IdType="pubmed">27069008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X., Luo Q., Zheng Y., Liu X., Hu Y., Wang F., Zou L. The role of Delta-like 4 ligand/Notch-ephrin-B2 cascade in the pathogenesis of preeclampsia by regulating functions of endothelial progenitor cell. Placenta. 2015;36:1002–1010. doi: 10.1016/j.placenta.2015.07.123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.placenta.2015.07.123</ArticleId>
            <ArticleId IdType="pubmed">26212082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Assis-Nascimento P., Tsenkina Y., Liebl D.J. EphB3 signaling induces cortical endothelial cell death and disrupts the blood-brain barrier after traumatic brain injury. Cell Death Dis. 2018;9:7. doi: 10.1038/s41419-017-0016-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-017-0016-5</ArticleId>
            <ArticleId IdType="pmc">PMC5849033</ArticleId>
            <ArticleId IdType="pubmed">29311672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Y., Tchkonia T., Pirtskhalava T., Gower A.C., Ding H., Giorgadze N., Palmer A.K., Ikeno Y., Hubbard G.B., Lenburg M., et al.  The Achilles’ heel of senescent cells: From transcriptome to senolytic drugs. Aging Cell. 2015;14:644–658. doi: 10.1111/acel.12344.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/acel.12344</ArticleId>
            <ArticleId IdType="pmc">PMC4531078</ArticleId>
            <ArticleId IdType="pubmed">25754370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rhodes C.J., Im H., Cao A., Hennigs J.K., Wang L., Sa S., Chen P.-I., Nickel N.P., Miyagawa K., Hopper R.K., et al.  RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension. Am. J. Respir. Crit. Care Med. 2015;192:356–366. doi: 10.1164/rccm.201408-1528OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201408-1528OC</ArticleId>
            <ArticleId IdType="pmc">PMC4584250</ArticleId>
            <ArticleId IdType="pubmed">26030479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huynh-Do U., Stein E., Lane A.A., Liu H., Cerretti D.P., Daniel T.O. Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through alphavbeta3 and alpha5beta1 integrins. EMBO J. 1999;18:2165–2173. doi: 10.1093/emboj/18.8.2165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/emboj/18.8.2165</ArticleId>
            <ArticleId IdType="pmc">PMC1171300</ArticleId>
            <ArticleId IdType="pubmed">10205170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stein E., Lane A.A., Cerretti D.P., Schoecklmann H.O., Schroff A.D., Van Etten R.L., Daniel T.O. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev. 1998;12:667–678. doi: 10.1101/gad.12.5.667.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.12.5.667</ArticleId>
            <ArticleId IdType="pmc">PMC316584</ArticleId>
            <ArticleId IdType="pubmed">9499402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fuller T., Korff T., Kilian A., Dandekar G., Augustin H.G. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells. J. Cell Sci. 2003;116:2461–2470. doi: 10.1242/jcs.00426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.00426</ArticleId>
            <ArticleId IdType="pubmed">12734395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Groeger G., Nobes C.D. Co-operative Cdc42 and Rho signalling mediates ephrinB-triggered endothelial cell retraction. Biochem. J. 2007;404:23–29. doi: 10.1042/BJ20070146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20070146</ArticleId>
            <ArticleId IdType="pmc">PMC1868826</ArticleId>
            <ArticleId IdType="pubmed">17300218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huynh-Do U., Vindis C., Liu H., Cerretti D.P., McGrew J.T., Enriquez M., Chen J., Daniel T.O. Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis. J. Cell Sci. 2002;115:3073–3081.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12118063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan C., Wang P., Zhu S., Zou T., Wang S., Xu J., Heng B.C., Diogenes A., Zhang C. EphrinB2 Stabilizes Vascularlike Structures Generated by Endothelial Cells and Stem Cells from Apical Papilla. J. Endod. 2016;42:1362–1370. doi: 10.1016/j.joen.2016.05.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.joen.2016.05.012</ArticleId>
            <ArticleId IdType="pubmed">27451120</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nagashima K., Endo A., Ogita H., Kawana A., Yamagishi A., Kitabatake A., Matsuda M., Mochizuki N. Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells. Mol. Biol. Cell. 2002;13:4231–4242. doi: 10.1091/mbc.e02-04-0181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1091/mbc.e02-04-0181</ArticleId>
            <ArticleId IdType="pmc">PMC138629</ArticleId>
            <ArticleId IdType="pubmed">12475948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bruhl T., Urbich C., Aicher D., Acker-Palmer A., Zeiher A.M., Dimmeler S. Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ. Res. 2004;94:743–751. doi: 10.1161/01.RES.0000120861.27064.09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.RES.0000120861.27064.09</ArticleId>
            <ArticleId IdType="pubmed">14764452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walshe J., Richardson N.A., Al Abdulsalam N.K., Stephenson S.A., Harkin D.G. A potential role for Eph receptor signalling during migration of corneal endothelial cells. Exp. Eye Res. 2018;170:92–100. doi: 10.1016/j.exer.2018.02.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.exer.2018.02.017</ArticleId>
            <ArticleId IdType="pubmed">29476773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao C., Huang Y., Tang Q., Zhang C., Shi L., Zhao J., Hu L., Hu Z., Liu Y., Chen L. Bidirectional juxtacrine ephrinB2/Ephs signaling promotes angiogenesis of ECs and maintains self-renewal of MSCs. Biomaterials. 2018;172:1–13. doi: 10.1016/j.biomaterials.2018.04.042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2018.04.042</ArticleId>
            <ArticleId IdType="pubmed">29709731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maekawa H., Oike Y., Kanda S., Ito Y., Yamada Y., Kurihara H., Nagai R., Suda T. Ephrin-B2 induces migration of endothelial cells through the phosphatidylinositol-3 kinase pathway and promotes angiogenesis in adult vasculature. Arterioscler. Thromb. Vasc. Biol. 2003;23:2008–2014. doi: 10.1161/01.ATV.0000096655.56262.56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.ATV.0000096655.56262.56</ArticleId>
            <ArticleId IdType="pubmed">14500293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bochenek M.L., Dickinson S., Astin J.W., Adams R.H., Nobes C.D. Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding. J. Cell Sci. 2010;123:1235–1246. doi: 10.1242/jcs.061903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.061903</ArticleId>
            <ArticleId IdType="pmc">PMC2848112</ArticleId>
            <ArticleId IdType="pubmed">20233847</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kida Y., Ieronimakis N., Schrimpf C., Reyes M., Duffield J.S. EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury. J. Am. Soc. Nephrol. Jasn. 2013;24:559–572. doi: 10.1681/ASN.2012080871.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2012080871</ArticleId>
            <ArticleId IdType="pmc">PMC3609137</ArticleId>
            <ArticleId IdType="pubmed">23492730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salvucci O., Maric D., Economopoulou M., Sakakibara S., Merlin S., Follenzi A., Tosato G. EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood. 2009;114:1707–1716. doi: 10.1182/blood-2008-12-192294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2008-12-192294</ArticleId>
            <ArticleId IdType="pmc">PMC2731645</ArticleId>
            <ArticleId IdType="pubmed">19411631</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brantley-Sieders D.M., Chen J. Eph receptor tyrosine kinases in angiogenesis: From development to disease. Angiogenesis. 2004;7:17–28. doi: 10.1023/B:AGEN.0000037340.33788.87.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1023/B:AGEN.0000037340.33788.87</ArticleId>
            <ArticleId IdType="pubmed">15302992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gavard J., Gutkind J.S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 2006;8:1223–1234. doi: 10.1038/ncb1486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb1486</ArticleId>
            <ArticleId IdType="pubmed">17060906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darling T.K., Mimche P.N., Bray C., Umaru B., Brady L.M., Stone C., Eboumbou Moukoko C.E., Lane T.E., Ayong L.S., Lamb T.J. EphA2 contributes to disruption of the blood-brain barrier in cerebral malaria. PLoS Pathog. 2020;16:e1008261.  doi: 10.1371/journal.ppat.1008261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1008261</ArticleId>
            <ArticleId IdType="pmc">PMC6991964</ArticleId>
            <ArticleId IdType="pubmed">31999807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woodruff T.M., Wu M.C., Morgan M., Bain N.T., Jeanes A., Lipman J., Ting M.J., Boyd A.W., Taylor S.M., Coulthard M.G. Epha4-Fc Treatment Reduces Ischemia/Reperfusion-Induced Intestinal Injury by Inhibiting Vascular Permeability. SHOCK. 2016;45:184–191. doi: 10.1097/SHK.0000000000000494.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/SHK.0000000000000494</ArticleId>
            <ArticleId IdType="pubmed">26771935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pfaff D., Heroult M., Riedel M., Reiss Y., Kirmse R., Ludwig T., Korff T., Hecker M., Augustin H.G. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes. J. Cell Sci. 2008;121:3842–3850. doi: 10.1242/jcs.030627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.030627</ArticleId>
            <ArticleId IdType="pubmed">18957513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tobia C., Chiodelli P., Nicoli S., Dell’era P., Buraschi S., Mitola S., Foglia E., van Loenen P.B., Alewijnse A.E., Presta M. Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. Arterioscler. Thromb. Vasc. Biol. 2012;32:e104–e116. doi: 10.1161/ATVBAHA.112.250035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.112.250035</ArticleId>
            <ArticleId IdType="pubmed">22837470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luxan G., Stewen J., Diaz N., Kato K., Maney S.K., Aravamudhan A., Berkenfeld F., Nagelmann N., Drexler H.C., Zeuschner D., et al.  Endothelial EphB4 maintains vascular integrity and transport function in adult heart. Elife. 2019;8 doi: 10.7554/eLife.45863.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.45863</ArticleId>
            <ArticleId IdType="pmc">PMC6884395</ArticleId>
            <ArticleId IdType="pubmed">31782728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tiruppathi C., Regmi S.C., Wang D.-M., Mo G.C.H., Toth P.T., Vogel S.M., Stan R.V., Henkemeyer M., Minshall R.D., Rehman J., et al.  EphB1 interaction with caveolin-1 in endothelial cells modulates caveolae biogenesis. Mol. Biol. Cell. 2020;31:1167–1182. doi: 10.1091/mbc.E19-12-0713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1091/mbc.E19-12-0713</ArticleId>
            <ArticleId IdType="pmc">PMC7353165</ArticleId>
            <ArticleId IdType="pubmed">32238105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vreeken D., Bruikman C., Cox S., Zhang H., Lalai R., Koudijs A., Zonneveld A., Hovingh G., Gils J. EPH receptor B2 stimulates human monocyte adhesion and migration independently of its EphrinB ligands. J. Leukoc. Biol. 2020 doi: 10.1002/JLB.2A0320-283RR.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/JLB.2A0320-283RR</ArticleId>
            <ArticleId IdType="pmc">PMC7496365</ArticleId>
            <ArticleId IdType="pubmed">32337793</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharfe N., Nikolic M., Cimpeon L., Van De Kratts A., Freywald A., Roifman C.M. EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactions. Mol. Immunol. 2008;45:1208–1220. doi: 10.1016/j.molimm.2007.09.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molimm.2007.09.019</ArticleId>
            <ArticleId IdType="pubmed">17980912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharfe N., Freywald A., Toro A., Dadi H., Roifman C. Ephrin stimulation modulates T cell chemotaxis. Eur. J. Immunol. 2002;32:3745–3755. doi: 10.1002/1521-4141(200212)32:12&lt;3745::AID-IMMU3745&gt;3.0.CO;2-M.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1521-4141(200212)32:12&lt;3745::AID-IMMU3745&gt;3.0.CO;2-M</ArticleId>
            <ArticleId IdType="pubmed">12516569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aasheim H.C., Delabie J., Finne E.F. Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2. Blood. 2005;105:2869–2876. doi: 10.1182/blood-2004-08-2981.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2004-08-2981</ArticleId>
            <ArticleId IdType="pubmed">15585656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ende G., Poitz D.M., Wiedemann E., Augstein A., Friedrichs J., Giebe S., Weinert S., Werner C., Strasser R.H., Jellinghaus S. TNF-alpha-mediated adhesion of monocytes to endothelial cells-The role of ephrinA1. J. Mol. Cell. Cardiol. 2014;77:125–135. doi: 10.1016/j.yjmcc.2014.10.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yjmcc.2014.10.010</ArticleId>
            <ArticleId IdType="pubmed">25451169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jellinghaus S., Poitz D.M., Ende G., Augstein A., Weinert S., Stutz B., Braun-Dullaeus R.C., Pasquale E.B., Strasser R.H. Ephrin-A1/EphA4-mediated adhesion of monocytes to endothelial cells. Biochim. Et Biophys. Acta. 2013;1833:2201–2211. doi: 10.1016/j.bbamcr.2013.05.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbamcr.2013.05.017</ArticleId>
            <ArticleId IdType="pubmed">23707953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finney A.C., Funk S.D., Green J., Yurdagul A., Rana M.A., Pistorius R., Henry M., Yurochko A.D., Pattillo C.B., Traylor J.G., et al.  EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis. Circulation. 2017 doi: 10.1161/CIRCULATIONAHA.116.026644.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.026644</ArticleId>
            <ArticleId IdType="pmc">PMC5548618</ArticleId>
            <ArticleId IdType="pubmed">28487392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Funk S.D., Finney A.C., Yurdagul A., Jr., Pattillo C.B., Orr A.W. EphA2 stimulates VCAM-1 expression through calcium-dependent NFAT1 activity. Cell. Signal. 2018;49:30–38. doi: 10.1016/j.cellsig.2018.05.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2018.05.008</ArticleId>
            <ArticleId IdType="pmc">PMC6680248</ArticleId>
            <ArticleId IdType="pubmed">29793020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan B., Sukhatme V.P. Receptor tyrosine kinase EphA2 mediates thrombin-induced upregulation of ICAM-1 in endothelial cells in vitro. Thromb. Res. 2009;123:745–752. doi: 10.1016/j.thromres.2008.07.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.thromres.2008.07.010</ArticleId>
            <ArticleId IdType="pmc">PMC2684450</ArticleId>
            <ArticleId IdType="pubmed">18768213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braun J., Hoffmann S.C., Feldner A., Ludwig T., Henning R., Hecker M., Korff T. Endothelial cell ephrinB2-dependent activation of monocytes in arteriosclerosis. Arterioscler. Thromb. Vasc. Biol. 2011;31:297–305. doi: 10.1161/ATVBAHA.110.217646.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.110.217646</ArticleId>
            <ArticleId IdType="pubmed">21127290</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakamoto A., Ishibashi-Ueda H., Sugamoto Y., Higashikata T., Miyamoto S., Kawashiri M.A., Yagi K., Konno T., Hayashi K., Fujino N., et al.  Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: From an aspect of chemotaxis. Clin. Sci. 2008;114:643–650. doi: 10.1042/CS20070339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/CS20070339</ArticleId>
            <ArticleId IdType="pubmed">18092944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kitamura T., Kabuyama Y., Kamataki A., Homma M.K., Kobayashi H., Aota S., Kikuchi S.-i., Homma Y. Enhancement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis. Am. J. Physiol. Cell Physiol. 2008;294:C189–C196. doi: 10.1152/ajpcell.00314.2007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpcell.00314.2007</ArticleId>
            <ArticleId IdType="pubmed">17942634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo H., Broux B., Wang X., Hu Y., Ghannam S., Jin W., Larochelle C., Prat A., Wu J. EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurobiol. Dis. 2016;91:292–306. doi: 10.1016/j.nbd.2016.03.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nbd.2016.03.013</ArticleId>
            <ArticleId IdType="pubmed">27039370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poitz D.M., Ende G., Stutz B., Augstein A., Friedrichs J., Brunssen C., Werner C., Strasser R.H., Jellinghaus S. EphrinB2/EphA4-mediated activation of endothelial cells increases monocyte adhesion. Mol. Immunol. 2015;68:648–656. doi: 10.1016/j.molimm.2015.10.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molimm.2015.10.009</ArticleId>
            <ArticleId IdType="pubmed">26552760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barquilla A., Pasquale E.B. Eph receptors and ephrins: Therapeutic opportunities. Annu. Rev. Pharmacol. Toxicol. 2015;55:465–487. doi: 10.1146/annurev-pharmtox-011112-140226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-pharmtox-011112-140226</ArticleId>
            <ArticleId IdType="pmc">PMC4388660</ArticleId>
            <ArticleId IdType="pubmed">25292427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cercone M.A., Schroeder W., Schomberg S., Carpenter T.C. EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009;297:L856–L863. doi: 10.1152/ajplung.00118.2009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajplung.00118.2009</ArticleId>
            <ArticleId IdType="pmc">PMC2777500</ArticleId>
            <ArticleId IdType="pubmed">19684201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park B.H., Shin M.H., Douglas I.S., Chung K.S., Song J.H., Kim S.Y., Kim E.Y., Jung J.Y., Kang Y.A., Chang J., et al.  Erythropoietin-Producing Hepatoma Receptor Tyrosine Kinase A2 Modulation Associates with Protective Effect of Prone Position in Ventilator-induced Lung Injury. Am. J. Respir. Cell Mol. Biol. 2018;58:519–529. doi: 10.1165/rcmb.2017-0143OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1165/rcmb.2017-0143OC</ArticleId>
            <ArticleId IdType="pubmed">29216437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ghori A., Freimann F.B., Nieminen-Kelhä M., Kremenetskaia I., Gertz K., Endres M., Vajkoczy P. EphrinB2 Activation Enhances Vascular Repair Mechanisms and Reduces Brain Swelling After Mild Cerebral Ischemia. Arterioscler. Thromb. Vasc. Biol. 2017;37:867–878. doi: 10.1161/ATVBAHA.116.308620.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.116.308620</ArticleId>
            <ArticleId IdType="pubmed">28254815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vivo V., Zini I., Cantoni A.M., Grandi A., Tognolini M., Castelli R., Ballabeni V., Bertoni S., Barocelli E. Protection by the EPH-EPHRIN System Against Mesenteric Ischemia-Reperfusion Injury. SHOCK. 2017 doi: 10.1097/SHK.0000000000000890.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/SHK.0000000000000890</ArticleId>
            <ArticleId IdType="pubmed">28472014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Welch C.L., Bretschger S., Latib N., Bezouevski M., Guo Y., Pleskac N., Liang C.P., Barlow C., Dansky H., Breslow J.L., et al.  Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model. Proc. Natl. Acad. Sci. USA. 2001;98:7946–7951. doi: 10.1073/pnas.141239098.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.141239098</ArticleId>
            <ArticleId IdType="pmc">PMC35448</ArticleId>
            <ArticleId IdType="pubmed">11438740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Q., Rao S., Shen G.Q., Li L., Moliterno D.J., Newby L.K., Rogers W.J., Cannata R., Zirzow E., Elston R.C., et al.  Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. Am. J. Hum. Genet. 2004;74:262–271. doi: 10.1086/381560.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/381560</ArticleId>
            <ArticleId IdType="pmc">PMC1181924</ArticleId>
            <ArticleId IdType="pubmed">14732905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang H., Li X., Zhang X., Liu Y., Huang S., Wang X. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice. Cardiovasc. Pathol. Off. J. Soc. Cardiovasc. Pathol. 2014;23:169–174. doi: 10.1016/j.carpath.2014.01.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.carpath.2014.01.006</ArticleId>
            <ArticleId IdType="pubmed">24561077</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
